Neoplasms, Hormone-Dependent
Information
- Disease name
- Neoplasms, Hormone-Dependent
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00044291 | Completed | Phase 3 | Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | June 2002 | January 2006 |
| NCT00748358 | Completed | Phase 2 | An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer | March 2008 | April 2011 |
| NCT00097344 | Terminated | Phase 3 | The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | December 2004 | August 2006 |
| NCT00267553 | Terminated | Phase 3 | Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer | November 2005 | June 2006 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D009376